PART 2: Gabor Maté and Alan Schwarz on "the Selling of Attention Deficit

PART 2: Gabor Maté and Alan Schwarz on "The Selling of Attention Deficit
In part two of our discussion with physician Gabor Maté and New York Times reporter Alan Schwarz, we discuss how attention deficit disorder manifests in children and adults, and how past abuse of drugs used to treat its symptoms helped lead to the … Read more on Democracy Now (blog)

Study looks at safety, effectiveness of generics for treating depression
Researchers at Washington University School of Medicine in St. Louis are studying the quality, effectiveness and safety of generic drugs used to treat depression. The research is supported by the U.S. Food and Drug Administration (FDA) and is the only … Read more on The Almagest

Hair loss shockers
Hair loss is a side effect of a number of medications taken for common health problems. Blood-thinning medications, oral contraceptives, drugs for depression, NSAIDs, and beta and calcium channel blockers can all lead to thinning hair or baldness. Too … Read more on Daily Ardmoreite

Pipeline: Major depressive disorder therapeutics
Major depressive disorder (MDD) is a significant health problem that is expected to be the leading cause of global disease burden by 2030. Antidepressants are the most popular treatment for MDD, but are plagued by a lack of efficacy, a slow onset of … Read more on PMLiVE

Holiday depression
With 24 Hour News 8’s Tony Tagliavia and Dr. Jared Skillings, the director of behavioral health at Pine Rest.